Chinese Regulatory Changes Key To Life Sciences Investment Decisions – BioMedical Asia
This article was originally published in The Pink Sheet Daily
Executive Summary
In the end, who wins and who loses in the Chinese life sciences market during the next few years will come down in large part to how health care reform plays out, panelists at the Singapore conference agreed.